fluoxetine has been researched along with ketanserin in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (11.76) | 18.7374 |
| 1990's | 33 (48.53) | 18.2507 |
| 2000's | 11 (16.18) | 29.6817 |
| 2010's | 15 (22.06) | 24.3611 |
| 2020's | 1 (1.47) | 2.80 |
| Authors | Studies |
|---|---|
| Baldessarini, RJ; Booth, RG; Charifson, PS; Kula, NS; McPhail, AT; Myers, AM; Owens, CE; Wyrick, SD | 1 |
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Caliendo, G; Capasso, R; Ciano, A; Corvino, A; Di Vaio, P; Fiorino, F; Frecentese, F; Izzo, AA; Kędzierska, E; Kotlińska, JH; Magli, E; Massarelli, P; Orzelska-Gòrka, J; Perissutti, E; Rossi, I; Saccone, I; Santagada, V; Severino, B | 1 |
| Jørgensen, H; Knigge, U; Warberg, J | 1 |
| Khan, IA; Thomas, P | 1 |
| Chen, HY; Lee, EH; Liang, KC; Lin, WR; Shiu, WH | 1 |
| Clifton, PG; Lee, MD | 1 |
| Brodkin, J; Nash, JF | 1 |
| Fone, KC; Marsden, CA; Robinson, AJ | 1 |
| Bhattacharya, SK; Datla, KP; Mitra, SK | 1 |
| Azmitia, EC; Murphy, RB; Whitaker-Azmitia, PM | 1 |
| Breese, GR; Duncan, GE; Hong, JS; Kuhn, C; Mueller, RA; Paul, IA | 1 |
| DeNoble, VJ; Spencer, KR; Strek, KF | 1 |
| Eison, AS; Eison, MS; Gianutsos, G; Yocca, FD | 1 |
| Schmidt, CJ; Taylor, VL | 1 |
| Lin, MT; Tsai, ML | 1 |
| Deis, RP; Jahn, GA | 1 |
| Byerley, WF; Dawson, TM; Grosser, BI; McCabe, RT; McConnell, EJ; Wamsley, JK | 1 |
| Peter, RE; Somoza, GM; Yu, KL | 1 |
| Bosin, TR; Mais, DE | 1 |
| Baker, GB; McManus, DJ; Todd, KG | 1 |
| Friedman, E; Tilakaratne, N; Yang, Z | 1 |
| Day, J; Fibiger, HC; Hirano, H | 1 |
| Hood, JS; Kadowitz, PJ; McMahon, TJ; Nossaman, BD | 1 |
| Klimek, V; Mackowiak, M; Zak-Knapik, J | 1 |
| Hussaini, IM; Musa, MH | 1 |
| Holtzman, SG; Steinfels, GF | 1 |
| Hrdina, PD; Vu, TB | 1 |
| Coote, JH; Lewis, DI; Sermasi, E | 1 |
| Cadogan, AK; Kendall, DA; Marsden, CA; Tulloch, I | 1 |
| Battaglia, G; Brownfield, MS; Cabrera, TM; Levy, AD; Li, Q; Rittenhouse, PA; van de Kar, LD | 1 |
| Malberg, JE; Sabol, KE; Seiden, LS | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Galloway, MP; Koch, S | 1 |
| Azmitia, EC; Kramer, HK; Poblete, JC | 1 |
| Battaglia, G; Li, Q; Muma, NA; Van de Kar, LD | 1 |
| Herges, S; Taylor, DA | 1 |
| Gean, PW; Lu, KT | 1 |
| Bennie, JG; Carroll, SM; Dow, RC; Fink, G; McQueen, JK | 1 |
| Aubin-Brunet, V; Bouhassira, M; Golmard, JL; Jouvent, R; Launay, JM; Mentré, F | 1 |
| Borda, E; Busch, L; Wald, M | 1 |
| Giovannini, MG; Pazzagli, M; Pepeu, G | 1 |
| Cousins, MS; Overstreet, DH; Seiden, LS; Vosmer, G | 1 |
| Capone, D; Ciancaglini, M; Costagliola, C; Mastropasqua, L; Pisanti, N; Verolino, M | 1 |
| Arai, Y; Hishinuma, T; Hozumi, M; Kinemuchi, H; Kisara, K; Mizugaki, M; Nakagawasai, O; Niijima, F; Oka, R; Satoh, N; Tadano, T; Tan-no, K; Yasuhara, H | 1 |
| Bayer, BM; Pellegrino, TC | 1 |
| Fantegrossi, WE; Godlewski, T; Karabenick, RL; Rice, KC; Stephens, JM; Ullrich, T; Woods, JH | 1 |
| Adnot, S; Eddahibi, S; Hamon, M; Marcos, E; Nosjean, A; Pham, MH; Raffestin, B | 1 |
| Bailey, SR; Berhane, Y; Elliott, J | 1 |
| Cavaillon, JM; Cloëz-Tayarani, I; Fanburg, BL; Kayyali, US | 1 |
| Bader, M; Lookingland, K; Murphy, DL; Ni, W; Watts, SW; Wilhelm, CS | 1 |
| Battaglia, G; Carrasco, GA; Damjanoska, KJ; Garcia, F; Grippo, AJ; Landry, M; Muma, NA; Shi, J; Singh, RK; Sullivan, NR | 1 |
| Endo, Y; Nakamura, M; Ohba, M; Ono, M; Sasano, T; Sugawara, S; Yu, Z | 1 |
| Lockridge, A; Su, J; Yuan, LL | 1 |
| Pazos, A; Pilar-Cuéllar, F; Vidal, R | 1 |
| Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G | 1 |
| Guner, I; Mengi, M; Sahin, G; Simsek, G; Sipahi, S; Yaman, O; Yelmen, N | 1 |
| Maraschin, M; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Anneken, JH; Gudelsky, GA | 1 |
| Barragán-Iglesias, P; Bravo-Hernández, M; Cervantes-Durán, C; Granados-Soto, V; Pineda-Farias, JB; Quiñonez-Bastidas, GN; Vidal-Cantú, GC | 1 |
| Decker, MJ; Galán, RF; Puzerey, PA | 1 |
| Antunes, MJ; Carvalho, F; Cotrim, MD; Fernandes, E; Silva, S | 1 |
| Becegato, M; Bioni, VS; Cunha, DMG; Kurita, JPF; Leão, AHFF; Lima, AC; Lopes-Silva, LB; Marinho, GF; Paiva-Santos, MA; Ribeiro, AM; Silva, RH; Wuo-Silva, R | 1 |
1 review(s) available for fluoxetine and ketanserin
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
67 other study(ies) available for fluoxetine and ketanserin
| Article | Year |
|---|---|
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor.
Topics: Animals; Ligands; Models, Molecular; Molecular Conformation; Receptors, sigma; Rodentia; Structure-Activity Relationship; Tetrahydronaphthalenes | 1994 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
New 5-HT
Topics: Animals; Binding Sites; Biological Assay; Ileum; Ligands; Maze Learning; Molecular Structure; Picolines; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Serotonin Receptor Agonists | 2017 |
Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Imidazoles; Indoles; Ketanserin; Male; Methysergide; Ondansetron; Prolactin; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Tropisetron | 1992 |
Stimulatory effects of serotonin on maturational gonadotropin release in the Atlantic croaker, Micropogonias undulatus.
Topics: Aging; Animals; Female; Fluoxetine; Gonadotropin-Releasing Hormone; Gonadotropins; In Vitro Techniques; Ketanserin; Male; Perciformes; Pituitary Gland; Serotonin; Sex Characteristics | 1992 |
Fluoxetine and 8-OH-DPAT in the lateral septum enhances and impairs retention of an inhibitory avoidance response in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Avoidance Learning; Brain Mapping; Dose-Response Relationship, Drug; Fear; Fluoxetine; Injections; Ketanserin; Male; Mental Recall; Rats; Rats, Inbred Strains; Receptors, Serotonin; Retention, Psychology; Ritanserin; Septum Pellucidum; Tetrahydronaphthalenes; Zimeldine | 1992 |
Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline.
Topics: Animals; Appetite Depressants; Eating; Fluoxetine; Habituation, Psychophysiologic; Ketanserin; Male; Metergoline; Milk; Rats; Serotonin Antagonists | 1992 |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluoxetine; Ketanserin; Male; Mazindol; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Clorgyline; Fluoxetine; Injections, Spinal; Ketanserin; Male; Motor Activity; Muscle Contraction; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes | 1991 |
Serotonergic modulation of footshock induced aggression in paired rats.
Topics: 5-Hydroxytryptophan; Aggression; Agonistic Behavior; Animals; Apomorphine; Citalopram; Clorgyline; Drug Interactions; Electroshock; Female; Fenclonine; Fluoxetine; Foot; Ketanserin; Male; Metergoline; Quipazine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1991 |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cells, Cultured; Embryo, Mammalian; Fluoxetine; Ketanserin; N-Methyl-3,4-methylenedioxyamphetamine; Raphe Nuclei; Rats; Serotonin | 1990 |
Neural adaptation in imipramine-treated rats processed in forced swim test: assessment of time course, handling, rat strain and amine uptake.
Topics: Adaptation, Physiological; Animals; Behavior, Animal; Cerebral Cortex; Corticosterone; Dihydroalprenolol; Fluoxetine; Hippocampus; Imipramine; Ketanserin; Male; Physical Exertion; Rats; Rats, Inbred F344; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, GABA-A; Species Specificity; Swimming | 1990 |
Manipulation of serotonin protects against an hypoxia-induced deficit of a passive avoidance response in rats.
Topics: Animals; Avoidance Learning; Cyproheptadine; Dose-Response Relationship, Drug; Fluoxetine; Hypoxia; Ketanserin; Male; Methysergide; Mianserin; Rats; Rats, Inbred Strains; Serotonin; Zimeldine | 1989 |
Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
Topics: 5,7-Dihydroxytryptamine; Animals; Cerebral Cortex; Cerebral Ventricles; Fluoxetine; Imipramine; Ketanserin; Kinetics; Male; Neurons; Quinolines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reference Values; Serotonin; Stereotyped Behavior | 1989 |
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Ketanserin; Kinetics; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Piperonyl Butoxide; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1987 |
Hypertension and tachycardia produced by inhibition of reuptake of 5-hydroxytryptamine by fluoxetine in the rat.
Topics: Adrenalectomy; Animals; Blood Pressure; Brain; Female; Fluoxetine; Heart Rate; Injections, Intraventricular; Ketanserin; Piperidines; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Vagotomy | 1986 |
Effect of serotonin antagonists on prolactin and progesterone secretion in rats: evidence that the stimulatory and inhibitory actions of serotonin on prolactin release may be mediated through different receptors.
Topics: 5-Hydroxytryptophan; Animals; Female; Fenclonine; Fluoxetine; Indoles; Ketanserin; Pregnancy; Proestrus; Progesterone; Prolactin; Rats; Receptors, Serotonin; Serotonin Antagonists; Tropisetron | 1988 |
Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
Topics: Animals; Antidepressive Agents; Autoradiography; Brain; Carrier Proteins; Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Ketanserin; Ligands; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Adrenergic, beta; Receptors, Drug; Receptors, Neurotransmitter; Receptors, Serotonin; Serotonin | 1987 |
Serotonin stimulates gonadotropin release in female and male goldfish, Carassius auratus L.
Topics: Animals; Dose-Response Relationship, Drug; Fluoxetine; Goldfish; Gonadotropins; Injections, Intraperitoneal; Ketanserin; Seasons; Serotonin; Time Factors | 1988 |
A role for serotonin in alpha-naphthylthiourea-induced pulmonary edema.
Topics: Animals; Blood Platelets; Clorgyline; Drug Interactions; Fluoxetine; Ketanserin; Lung; Male; Mice; Piperidines; Pulmonary Edema; Reserpine; Serotonin; Serotonin Antagonists; Thiourea; Thrombocytopenia | 1984 |
Chronic administration of the antidepressants phenelzine, desipramine, clomipramine, or maprotiline decreases binding to 5-hydroxytryptamine2A receptors without affecting benzodiazepine binding sites in rat brain.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Brain; Clomipramine; Desipramine; Flunitrazepam; Fluoxetine; Ketanserin; Male; Maprotiline; Phenelzine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, GABA-A; Receptors, Serotonin; Serotonin Antagonists | 1995 |
Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.
Topics: Amphetamines; Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Desipramine; Fluoxetine; Gene Expression; Genes, fos; Hippocampus; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; RNA; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
Serotonergic regulation of acetylcholine release in rat frontal cortex.
Topics: Acetylcholine; Animals; Benzazepines; Dialysis; Fenfluramine; Fluoxetine; Frontal Lobe; Ketanserin; Kinetics; Male; Rats; Rats, Wistar; Serotonin | 1995 |
Analysis of responses to serotonin in the pulmonary vascular bed of the cat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Animals; Arginine; Blood Pressure; Bronchi; Cats; Female; Fluoxetine; In Vitro Techniques; Ketanserin; Male; Meclofenamic Acid; Muscle Tonus; NG-Nitroarginine Methyl Ester; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Serotonin; Thromboxane A2; Vascular Resistance; Vasoconstrictor Agents | 1993 |
Effects of repeated treatment with fluoxetine and citalopram, 5-HT uptake inhibitors, on 5-HT1A and 5-HT2 receptors in the rat brain.
Topics: Animals; Antidepressive Agents; Binding Sites; Brain; Citalopram; Fluoxetine; Ketanserin; Male; Maprotiline; Rats; Rats, Wistar; Receptors, Serotonin; Serotonin | 1994 |
Fluoxetine potentiates nitrazepam-induced behavioral sleep in young chicks.
Topics: Animals; Chickens; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Ketanserin; Male; Nitrazepam; Sleep | 1994 |
Monoamine systems in the discriminative effects of spiradoline, a kappa-opioid agonist.
Topics: Analgesics; Animals; Avoidance Learning; Biogenic Monoamines; Discrimination, Psychological; Dopamine Antagonists; Fenfluramine; Fluoxetine; Generalization, Stimulus; Ketanserin; Male; Piperidines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission | 1994 |
Chronic fluoxetine treatment upregulates 5-HT uptake sites and 5-HT2 receptors in rat brain: an autoradiographic study.
Topics: Animals; Autoradiography; Brain Chemistry; Fluoxetine; Image Processing, Computer-Assisted; Ketanserin; Male; Mianserin; Paroxetine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Up-Regulation | 1993 |
Excitatory and indirect inhibitory actions of 5-hydroxytryptamine on sympathetic preganglionic neurones in the neonate rat spinal cord in vitro.
Topics: Action Potentials; Animals; Animals, Newborn; Autonomic Fibers, Preganglionic; Female; Fluoxetine; Glycine; In Vitro Techniques; Interneurons; Ketanserin; Male; Membrane Potentials; Neurons; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Receptor Agonists; Spinal Cord; Strychnine; Sympathetic Nervous System | 1993 |
Evidence that chronic administration of paroxetine or fluoxetine enhances 5-HT2 receptor function in the brain of the guinea pig.
Topics: Amitriptyline; Animals; Brain Chemistry; Calcimycin; Calcium; Cerebral Cortex; Female; Fluoxetine; Guinea Pigs; In Vitro Techniques; Inositol; Ketanserin; Male; Paroxetine; Phosphatidylinositols; Receptors, Serotonin; Serotonin; Serotonin Antagonists | 1993 |
Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Desipramine; Drug Synergism; Fluoxetine; Hormones; Ketanserin; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Vasopressins | 1993 |
Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.
Topics: Animals; Body Temperature; Drug Combinations; Fluoxetine; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Tyrosine | 1996 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
MDMA induced dopamine release in vivo: role of endogenous serotonin.
Topics: Animals; Chromatography, High Pressure Liquid; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; In Vitro Techniques; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Antagonists | 1997 |
Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Topics: Animals; Binding Sites; Brain; Brain Stem; Carrier Proteins; Cerebral Cortex; Enzyme Activation; Female; Fluoxetine; Hippocampus; Ketanserin; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins | 1997 |
Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins.
Topics: Amphetamines; Animals; Cerebral Cortex; Fluoxetine; GTP-Binding Proteins; Hypothalamus; Immunoblotting; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Involvement of serotonin in the modulation of cocaine-induced locomotor activity in the rat.
Topics: Animals; Behavior, Animal; Cocaine; Drug Interactions; Female; Fluoxetine; Ketanserin; Methysergide; Motor Activity; Narcotics; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 1998 |
Endogenous serotonin inhibits epileptiform activity in rat hippocampal CA1 neurons via 5-hydroxytryptamine1A receptor activation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Barium; Epilepsy; Excitatory Postsynaptic Potentials; Fluoxetine; Hippocampus; In Vitro Techniques; Ketanserin; Male; Membrane Potentials; Metergoline; Neurons; Oxadiazoles; Picrotoxin; Piperazines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synaptic Transmission; Tryptamines | 1998 |
Serotonergic 5-HT2A receptors important for the oestradiol-induced surge of luteinising hormone-releasing hormone in the rat.
Topics: Anesthesia; Anesthetics; Animals; Cyclic S-Oxides; Diestrus; Estradiol; Female; Fluoxetine; Gonadotropin-Releasing Hormone; Ketanserin; Naphthalenes; Ovariectomy; Pituitary Gland; Pregnanediones; Proestrus; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 1999 |
Relationships between low red blood cell count and clinical response to fluoxetine in depressed elderly patients.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Blood Platelets; Carrier Proteins; Depressive Disorder, Major; Erythrocyte Count; Female; Fluoxetine; Humans; Ketanserin; Male; Middle Aged; Personality Inventory; Receptors, Drug; Serotonin; Treatment Outcome; Tryptophan | 1998 |
Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility.
Topics: Adrenergic Agents; Animals; Antidepressive Agents, Second-Generation; Binding Sites; Calcium; Cyclooxygenase Inhibitors; Fluoxetine; Indomethacin; Isoproterenol; Ketanserin; Male; Muscle Contraction; Nitroprusside; Norepinephrine; Prazosin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vas Deferens; Verapamil | 1999 |
Trazodone increases extracellular serotonin levels in the frontal cortex of rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Carrier Proteins; Cerebral Cortex; Fluoxetine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Trazodone | 1999 |
Rats selectively bred for responsiveness to 5-hydroxytryptamine(1A) receptor stimulation: differences in differential reinforcement of low rate 72-second performance and response to serotonergic drugs.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Age Factors; Animals; Behavior, Animal; Biogenic Monoamines; Brain Chemistry; Conditioning, Operant; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Hypothermia; Ketanserin; Male; Rats; Receptors, Serotonin; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2000 |
Effect of fluoxetine on intraocular pressure in the rabbit.
Topics: Administration, Topical; Animals; Antidepressive Agents; Diuresis; Female; Fluoxetine; Hydroxyindoleacetic Acid; Injections, Intravenous; Intraocular Pressure; Ketanserin; Male; Rabbits; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2000 |
Central serotonergic mechanisms on head twitch response induced by benzodiazepine receptor agonists.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Azabicyclo Compounds; Behavior, Animal; Dihydroxytryptamines; Estazolam; Fluoxetine; GABA-A Receptor Agonists; Hypnotics and Sedatives; Ketanserin; Male; Mice; Piperazines; Receptors, GABA-A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists; Triazolam | 2001 |
Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity.
Topics: Animals; Fluoxetine; Immunosuppression Therapy; Injections; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; T-Lymphocytes | 2002 |
Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Topics: Animals; Body Temperature; Cold Temperature; Crowding; Dose-Response Relationship, Drug; Fluorobenzenes; Fluoxetine; Hallucinogens; Ketanserin; Lethal Dose 50; Male; Mice; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Platelet Aggregation Inhibitors; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Isolation; Stereoisomerism; Telemetry | 2003 |
Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension.
Topics: Analysis of Variance; Animals; Carrier Proteins; Chronic Disease; Citalopram; Disease Models, Animal; Fluoxetine; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Muscle, Smooth, Vascular; Nerve Tissue Proteins; Oxadiazoles; Piperazines; Pulmonary Artery; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Statistics, Nonparametric | 2003 |
Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets.
Topics: Adrenergic alpha-Agonists; Animals; Biogenic Amines; Blood Platelets; Cecum; Cystamine; Femoral Artery; Femoral Vein; Fluoxetine; Horses; In Vitro Techniques; Isometric Contraction; Ketanserin; Male; Muscle, Smooth, Vascular; Platelet Activation; Serotonin Antagonists; Vasoconstriction | 2003 |
5-HT activates ERK MAP kinase in cultured-human peripheral blood mononuclear cells via 5-HT1A receptors.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Cells, Cultured; Dose-Response Relationship, Drug; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Humans; Immunologic Factors; Ketanserin; Leukocytes, Mononuclear; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Serotonin; Serotonin 5-HT1 Receptor Agonists | 2004 |
(+)-Norfenfluramine-induced arterial contraction is not dependent on endogenous 5-hydroxytryptamine or 5-hydroxytryptamine transporter.
Topics: Animals; Aorta; Fluoxetine; Fluvoxamine; Ketanserin; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Norfenfluramine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tryptophan Hydroxylase; Vasoconstriction | 2005 |
Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
Topics: Amphetamines; Animals; Cell Culture Techniques; Cell Line; Fluoxetine; Frontal Lobe; GTP-Binding Protein alpha Subunits, Gq-G11; Ketanserin; Male; Phosphorylation; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Signal Transduction; Transfection; Type C Phospholipases | 2007 |
Dynamics of platelet mobilisation into lungs in response to 5-hydroxytryptamine (serotonin) in mice.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Cell Movement; Fluoxetine; Histamine; Injections, Intravenous; Ketanserin; Lung; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Microscopy, Electron, Transmission; Platelet Count; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists | 2009 |
Abnormal 5-HT modulation of stress behaviors in the Kv4.2 knockout mouse.
Topics: Animals; Behavior, Animal; Fluoxetine; Head; Ketanserin; Mice; Mice, Knockout; Movement; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Shal Potassium Channels; Stress, Psychological | 2010 |
Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; beta Catenin; Brain-Derived Neurotrophic Factor; Fluoxetine; Hippocampus; Ketanserin; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Swimming | 2012 |
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fetus; Fluoxetine; Hemodynamics; Hypertension, Pulmonary; Hysterotomy; Indoles; Ketanserin; Lung; Oxadiazoles; Piperazines; Pregnancy; Pulmonary Artery; Pyridines; Receptors, Serotonin; rho-Associated Kinases; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep; Vascular Resistance | 2011 |
Alterations of central hypercapnic respiratory response induced by acute central administration of serotonin re-uptake inhibitor, fluoxetine.
Topics: Animals; Brain; Carbon Dioxide; Fluoxetine; Hypercapnia; Injections, Intraventricular; Ketanserin; Male; Rabbits; Respiration; Selective Serotonin Reuptake Inhibitors | 2011 |
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Coumaric Acids; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Immobility Response, Tonic; Ketanserin; Male; Mice; Motor Activity; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sertraline | 2012 |
MDMA produces a delayed and sustained increase in the extracellular concentration of glutamate in the rat hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Chromatography, High Pressure Liquid; Extracellular Space; Fluoxetine; Glutamic Acid; Hippocampus; Ketanserin; Male; Microdialysis; N-Methyl-3,4-methylenedioxyamphetamine; Neostriatum; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sodium Channel Blockers; Tetrodotoxin | 2012 |
Evidence for the participation of peripheral 5-HT₂A, 5-HT₂B, and 5-HT₂C receptors in formalin-induced secondary mechanical allodynia and hyperalgesia.
Topics: Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Formaldehyde; Hyperalgesia; Ketanserin; p-Methoxy-N-methylphenethylamine; Pyrimidines; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides | 2013 |
Elevated serotonergic signaling amplifies synaptic noise and facilitates the emergence of epileptiform network oscillations.
Topics: Animals; Computer Simulation; Electrodes, Implanted; Electroencephalography; Epilepsy; Excitatory Postsynaptic Potentials; Fluoxetine; Ketanserin; Mice, Inbred C57BL; Models, Neurological; Neurons; Patch-Clamp Techniques; Pentylenetetrazole; Periodicity; Receptors, Serotonin, 5-HT2; Receptors, Serotonin, 5-HT3; Selective Serotonin Reuptake Inhibitors; Serotonin; Somatosensory Cortex; Synaptic Transmission; Thalamus; Tissue Culture Techniques | 2014 |
Contractile effects of 3,4-methylenedioxymethamphetamine on the human internal mammary artery.
Topics: Fluoxetine; Hallucinogens; Humans; In Vitro Techniques; Isometric Contraction; Ketanserin; Mammary Arteries; N-Methyl-3,4-methylenedioxyamphetamine; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins | 2016 |
Memory and anxiety-like behavior of rats in the plus-maze discriminative avoidance task: Role of serotonergic transmission in the basolateral amygdala.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anxiety; Avoidance Learning; Basolateral Nuclear Complex; Fluoxetine; Ketanserin; Male; Rats; Rats, Wistar; Serotonin | 2023 |